Coya Therapeutics, Inc. (COYA) Tops Q3 EPS by 46c

Coya Therapeutics, Inc. (NASDAQ: COYA) reported Q3 EPS of ($0.13), $0.46 better than the analyst estimate of ($0.59). Revenue for the quarter came in at $3.56 million, versus $0 reported last year.

For earnings history and earnings-related data on Coya Therapeutics, Inc. (COYA) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
• Kroger (KR) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY27 EPS Guidance